Similarly, our data indicated that hypertension APs not only had higher WBCs, neutrophils, basophils, IL-6, and CRP levels but also had lower virus-specific IgM levels than non-hypertension APs, which further immunologically confirms that hypertension had adverse effects on COVID-19 APs. This evidence concerns the gene IL6 and hypertensive disorder.